Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hemostasis and Thrombosis Center of Nevada is a Nevada-based nonprofit specialty healthcare organization and the state's only federally recognized hemophilia treatment center. It provides multidisciplinary diagnosis, treatment, care coordination, and support services for patients with inherited bleeding and clotting disorders, and it also operates the Sickle Cell Center of Nevada for pediatric sickle cell care and related support programs. The organization runs clinical sites in Las Vegas and Reno and participates in federally supported programs including HRSA-linked sickle cell initiatives. Rather than developing proprietary therapeutics, HTCNV functions as a care delivery organization focused on comprehensive hematology services, patient education, outreach, and community support for rare blood disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hemostasis and Thrombosis Center of Nevada.